NEW YORK (GenomeWeb News) - GE Healthcare today said that second-quarter revenues climbed 10 percent as earnings increased 18 percent.
 
For the quarter ended June 30, GE Healthcare had $4.1 billion in revenues, up from $3.8 billion during the same quarter in 2005.
 
GE Healthcare's earnings for the quarter increased to $795 million from $672 million in the second quarter of 2005.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.